Results 41 to 50 of about 120,934 (309)

Precision Medicine for Gastric Cancer: Current State of Organoid Drug Testing

open access: yesOrganoids
Gastric cancer (GC) presents a significant health challenge and ranks as the fifth most common cancer in the world. Unfortunately, most patients with GC exhaust standard care treatment options due to late diagnosis and tumour heterogeneity that leads to ...
Tharindie N. Silva   +3 more
doaj   +1 more source

Pre-diagnostic colonoscopies reduce cancer mortality - results from linked population-based data in South Australia

open access: yesBMC Cancer, 2019
Background To investigate the association between pre-diagnostic colonoscopy and colorectal cancer mortality in South Australia. Methods Colonoscopy histories were obtained for colorectal cancer patients diagnosed in 2003–2013 using linked Medical ...
Ming Li   +11 more
doaj   +1 more source

Colonoscopies in Australia – how much does the National Bowel Cancer Screening Program contribute to colonoscopy use?

open access: yesPublic Health Research & Practice, 2023
Objectives and importance of study: Colorectal cancer (CRC) is Australia’s fourth most commonly diagnosed cancer. CRC screening is an effective intervention to reduce this burden.
Joachim Worthington   +7 more
doaj   +1 more source

The varying role of the GP in the pathway between colonoscopy and surgery for colorectal cancer: a retrospective cohort study [PDF]

open access: yes, 2013
Extent: 11p. Data source: Supplementary data, https://www.saxinstitute.org.au/our-work/45-up-study/Objectives: To describe general practitioner (GP) involvement in the treatment referral pathway for colorectal cancer (CRC) patients.
Harris, M.   +19 more
core   +1 more source

Compliance with Quality Standards and Causes of Incomplete Colonoscopy: A Prospective Observational Study

open access: yesTurkish Journal of Colorectal Disease, 2019
Aim: To evaluate incomplete colonoscopy rate, factors affecting incomplete colonoscopy, and compliance with colonoscopy quality standards in our clinic.
Ulaş Aday   +7 more
doaj   +1 more source

Training in Endoscopy: Colonoscopy [PDF]

open access: yesClinical Endoscopy, 2017
Colonoscopy is effective in reducing the morbidity and mortality associated with colorectal cancer (CRC). Interval cancers or post-colonoscopy CRCs, are cancers detected within the surveillance interval, or between 6–36 months after a clearing ...
Hyun Joo Jang
doaj   +1 more source

The Difficult Colonoscopy [PDF]

open access: yesCanadian Journal of Gastroenterology, 2007
Colorectal cancer is the most common cause of cancer-related death among nonsmokers in Canada (1) and is the second leading cause of cancer mortality overall. It is estimated that in 2007, approximately 21,000 Canadians will be diagnosed with colorectal cancer and that nearly 9000 will die from it (2).
Todd N Witte, Robert Enns
openaire   +3 more sources

From mice to humans—divergent strategies for intestinal homeostasis and regeneration

open access: yesFEBS Letters, EarlyView.
Recent advances such as organoid genome editing, xenotransplantation, imaging, and whole‐genome sequencing have enabled direct studies of human intestinal stem cells (ISCs). These studies reveal species‐specific features, including slower ISC proliferation, distinct injury responses, slower somatic mutation accumulation in humans, and an inverse ...
Keiko Ishikawa   +2 more
wiley   +1 more source

Intramural Hematoma and Retroperitoneal Hematoma Following a Routine Colonoscopy: An Uncommon Complication of a Common Procedure

open access: yesCase Reports in Gastroenterology, 2022
Colonoscopy is used worldwide for screening colon cancer. Routine colonoscopy is considered a safe procedure with relatively fewer adverse events. We present a case of intracolonic and retroperitoneal hematoma following a routine colonoscopy.
Ayesha Jalal   +3 more
doaj   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy